Milnes Alistair
SEC CIK 1901321 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BCYC | BICYCLE THERAPEUTICS PLC | COO | 140.1K | — | $364.0K | 19 | 2022-01-03 | 2026-01-02 |
Most active insiders at BCYC, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Lee Kevin | CEO, Dir | — | $258.0K |
| 2 | Skynner Michael | CTO | — | $79.1K |
| 3 | Milnes Alistair | COO | — | $62.0K |
| 4 | Hannay Michael Charles Ferguson | CHIEF PROD, SUPPLY CHAIN OFF | — | $56.8K |
| 5 | Young Alethia | CFO | — | $54.6K |
| 6 | Thompson Travis Alvin | CFO | — | $27.3K |
| 7 | Perry Jennifer Scott | COO | — | $13.0K |
| 8 | Swanton Robert Charles | Dir | — | $872.10 |
| 9 | Sands Stephen H. | Dir | — | — |
| 10 | Riva Alessandro | Dir | — | — |
Transactions 19
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-01-06 | 2026-01-02+ | BCYC | BICYCLE THERAPEUTICS PLC | Milnes Alistair | COO | S - Sale | $6.63 | -6,660 | 140.1K | -5% | -$44.1K |
| D | 2026-01-06 | 2026-01-02 | BCYC | BICYCLE THERAPEUTICS PLC | Milnes Alistair | COO | A - Grant | $0.00 | +50.0K | 143.4K | +54% | $0 |
| M | 2025-10-06 | 2025-10-02+ | BCYC | BICYCLE THERAPEUTICS PLC | Milnes Alistair | COO | S - Sale | $8.40 | -2,125 | 94.4K | -2% | -$17.9K |
| M | 2025-07-07 | 2025-07-02+ | BCYC | BICYCLE THERAPEUTICS PLC | Milnes Alistair | COO | S - Sale | $7.25 | -2,115 | 95.5K | -2% | -$15.3K |
| M | 2025-04-04 | 2025-04-02+ | BCYC | BICYCLE THERAPEUTICS PLC | Milnes Alistair | COO | S - Sale | $7.76 | -2,171 | 98.7K | -2% | -$16.9K |
| DM | 2025-01-06 | 2025-01-02+ | BCYC | BICYCLE THERAPEUTICS PLC | Milnes Alistair | COO | S - Sale | $14.20 | -5,514 | 100.7K | -5% | -$78.3K |
| D | 2025-01-06 | 2025-01-02 | BCYC | BICYCLE THERAPEUTICS PLC | Milnes Alistair | COO | A - Grant | $0.00 | +35.0K | 105.3K | +50% | $0 |
| 2024-10-04 | 2024-10-03 | BCYC | BICYCLE THERAPEUTICS PLC | Milnes Alistair | COO | S - Sale | $22.26 | -972 | 70.3K | -1% | -$21.6K | |
| 2024-07-08 | 2024-07-03 | BCYC | BICYCLE THERAPEUTICS PLC | Milnes Alistair | COO | S - Sale | $19.64 | -967 | 71.3K | -1% | -$19.0K | |
| 2024-04-05 | 2024-04-03 | BCYC | BICYCLE THERAPEUTICS PLC | Milnes Alistair | COO | S - Sale | $23.81 | -955 | 72.2K | -1% | -$22.7K | |
| D | 2024-01-04 | 2024-01-02 | BCYC | BICYCLE THERAPEUTICS PLC | Milnes Alistair | COO | A - Grant | $0.00 | +39.0K | 75.8K | +106% | $0 |
| D | 2024-01-04 | 2024-01-03 | BCYC | BICYCLE THERAPEUTICS PLC | Milnes Alistair | COO | S - Sale | $17.50 | -2,643 | 73.2K | -3% | -$46.3K |
| 2023-10-05 | 2023-10-03 | BCYC | BICYCLE THERAPEUTICS PLC | Milnes Alistair | COO | S - Sale | $20.00 | -442 | 36.8K | -1% | -$8,840 | |
| 2023-07-06 | 2023-07-03 | BCYC | BICYCLE THERAPEUTICS PLC | Milnes Alistair | COO | S - Sale | $25.10 | -451 | 37.3K | -1% | -$11.3K | |
| 2023-04-05 | 2023-04-03 | BCYC | BICYCLE THERAPEUTICS PLC | Milnes Alistair | COO | S - Sale | $21.11 | -447 | 37.7K | -1% | -$9,436 | |
| D | 2023-01-05 | 2023-01-03 | BCYC | BICYCLE THERAPEUTICS PLC | Milnes Alistair | COO | A - Grant | $0.00 | +17.5K | 40.0K | +78% | $0 |
| D | 2023-01-05 | 2023-01-03 | BCYC | BICYCLE THERAPEUTICS PLC | Milnes Alistair | COO | S - Sale | $29.06 | -1,801 | 38.2K | -5% | -$52.3K |
| D | 2022-03-29 | 2022-03-25 | BCYC | BICYCLE THERAPEUTICS PLC | Milnes Alistair | COO | M - OptEx | $20.12 | +5,155 | 22.5K | +30% | +$103.7K |
| D | 2022-01-05 | 2022-01-03 | BCYC | BICYCLE THERAPEUTICS PLC | Milnes Alistair | COO | A - Grant | $0.00 | +15.0K | 15.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations